Cited by 1,589COVID-19 and healthcare impactsCOVID-19 Clinical Research StudiesCOVID-19 Impact on Reproduction

The DOI matches its Crossref record; 23 of the 27 references it cites were found in a registry or an index.

Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak

Open access

Dai, Mengyuan, Liu, Dianbo, Liu, Miao, Zhou, Fuxiang, Li, Guiling, Chen, Zhen, Zhang, Zhian, You, Hua, Wu, Meng, Zheng, Qichao, Xiong, Yong, Xiong, Huihua, Wang, Chun, Chen, Changchun, Xiong, Fei, Zhang, Yan, Peng, Yaqin, Ge, Siping, Zhen, Bo, Yu, Tingting, Wang, Ling, Wang, Hua, Liu, Yu, Chen, Yeshan, Mei, Junhua, Gao, Xiaojia, Li, Zhuyan, Gan, Lijuan, He, Can, Li, Zhen, Shi, Yuying, Qi, Yuwen, Yang, Jing, Tenen, Daniel G., Chai, Li, Mucci, Lorelei A., Santillana, Mauricio, Cai, Hongbing·2020·Cancer Discovery

DOI 10.1158/2159-8290.cd-20-0422PMC PMC7309152

Open this paper in CoChat — free account Open PDF

Abstract

Abstract The novel COVID-19 outbreak has affected more than 200 countries and territories as of March 2020. Given that patients with cancer are generally more vulnerable to infections, systematic analysis of diverse cohorts of patients with cancer affected by COVID-19 is needed. We performed a multicenter study including 105 patients with cancer and 536 age-matched noncancer patients confirmed with COVID-19. Our results showed COVID-19 patients with cancer had higher risks in all severe outcomes. Patients with hematologic cancer, lung cancer, or with metastatic cancer (stage IV) had the highest frequency of severe events. Patients with nonmetastatic cancer experienced similar frequencies of severe conditions to those observed in patients without cancer. Patients who received surgery had higher risks of having severe events, whereas patients who underwent only radiotherapy did not demonstrate significant differences in severe events when compared with patients without cancer. These findings indicate that patients with cancer appear more vulnerable to SARS-CoV-2 outbreak. Significance: Because this is the first large cohort study on this topic, our report will provide much-needed information that will benefit patients with cancer globally. As such, we believe it is extremely important that our study be disseminated widely to alert clinicians and patients. This article is highlighted in the In This Issue feature, p. 747

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1158/2159-8290.cd-20-0422

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Self-citation
Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study.
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Self-citation
Cancer statistics in China, 2015
Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X. Q., & He, J. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21338 · Cited by 17,038
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
Self-citation
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
Liang, W., Guan, W., Chen, R., Wang, W., Li, J., Xu, K., Li, C., Ai, Q., Lu, W., Liang, H., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30096-6 · Cited by 4,384
Multiple myeloma
Raje, N. S., & Anderson, K. C. (2000) · Current Treatment Options in Oncology · doi:10.1007/s11864-000-0017-x · Cited by 2,164
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
Russell, C. D., Millar, J. E., & Baillie, J. K. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30317-2 · Cited by 2,040

Show all 27 references

Sorted by citations

Items 501–600 of 1,001

SARS-CoV-2-associated gut microbiome alteration; A new contributor to colorectal cancer pathogenesis
Mozaffari, S. A., Salehi, A., Mousavi, E., Zaman, B. A., Nassaj, A. E., Ebrahimzadeh, F., Nasiri, H., Valedkarimi, Z., Adili, A., Asemani, G., et al. (2022) · Pathology - Research and Practice · doi:10.1016/j.prp.2022.154131 · Cited by 13
Health influence of SARS-CoV-2 (COVID-19) on cancer: a review
Parise, R., Li, Y. E., Nadar, R. M., Ramesh, S., Ren, J., Govindarajulu, M., Moore, T. M., & Dhanasekaran, M. (2022) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2022147 · Cited by 13
COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination
Salvatore, M., Hu, M. M., Beesley, L. J., Mondul, A. M., Pearce, C. L., Friese, C. R., Fritsche, L. G., & Mukherjee, B. (2023) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-22-0607 · Cited by 12
Clinical features and death risk factors in COVID-19 patients with cancer: a retrospective study
Zhou, Y., Yang, Q., Ye, J., Wu, X., Hou, X., Feng, Y., Luo, B., Li, J., Yang, G., Li, L., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06495-9 · Cited by 13
The state of neuro-oncology during the COVID-19 pandemic: a worldwide assessment
Mrugała, M. M., Ostrom, Q. T., Pressley, S. M., Taylor, J. W., Thomas, A. A., Wefel, J. S., Coven, S. L., Acquaye, A., Haynes, C., Agnihotri, S., et al. (2021) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdab035 · Cited by 13
The Role and Impact of Social Media in Cardio-oncology During the COVID-19 Pandemic
Kwan, J. M., Henry, M. L., Christophers, B., Tamirisa, K. P., Thamman, R., Sadler, D. B., Aggarwal, N. R., Cheng, R. K.-H., Parwani, P. J., Dent, S. F., et al. (2021) · Current Oncology Reports · doi:10.1007/s11912-021-01081-3 · Cited by 13
Clinical characteristics, risk factors, and cardiac manifestations of cancer patients with COVID-19
Huang, Y., Hu, Z., Hu, D., Quan, Z., Zhou, X., Fan, G., Chen, X., Liu, X., Zhang, Z., Chen, G., et al. (2021) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00325.2021 · Cited by 13
Self-citation
Psychological health status among thyroid cancer patients during the COVID-19 epidemic in China
Yang, S., Wang, J., & Xu, X. (2021) · Supportive Care in Cancer · doi:10.1007/s00520-021-06624-9 · Cited by 12
Rapidly fatal pneumonitis from immunotherapy and concurrent SARS-CoV-2 infection in a patient with newly diagnosed lung cancerPreprint
Lovly, C. M., Boyd, K. L., Ericsson, P. I. G., Lowe, C. L., Brown, H. M., Hoffman, R., Sterling, B. C., Kapp, M., Johnson, D. B., Kopparapu, P., et al. (2020) · medRxiv · doi:10.1101/2020.04.29.20085738 · Cited by 13
Impact of the COVID-19 crisis on imaging in oncological trials
Deroose, C. M., Lecouvet, F. E., Collette, L., Oprea-Lager, D. E., Kunz, W. G., Bidaut, L., Verhoeff, J. J. C., Caramella, C., Lopci, E., Tombal, B., et al. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04910-y · Cited by 12
An Asian Perspective of the Management of COVID-19: the Asian National Cancer Centers Alliance Led Regional Comparison
Dewi, L. K. M., Gatellier, L., Sabapathy, K., Pramesh, C. S., Dai, M., Huong, T. T., Gültekin, M., Nansalmaa, E., Htwe, K. K., Yusuf, M. A., et al. (2020) · Asian Pacific Journal of Cancer Care · doi:10.31557/apjcc.2020.5.s1.27-42 · Cited by 12
Self-citation
Epidemiological Characteristics of COVID-19 Cases in A University Hospital in Turkey
TEKER, A. G., Emecen, A. N., Girgin, S., Şimşek, H., Şiyve, N., Sezgin, E., ŞENSOY, E. B., Yıldırım-Karalar, K., Appak, Ö., Nazlı, A., et al. (2021) · Klimik Dergisi/Klimik Journal · doi:10.36519/kd.2021.11 · Cited by 12
Microsurgical autologous breast reconstruction in the midst of a pandemic: A single-unit COVID-19 experience
Ho, W., Köhler, G., Haywood, R. M., Rosich‐Medina, A., & Masud, D. (2021) · Journal of Plastic Reconstructive & Aesthetic Surgery · doi:10.1016/j.bjps.2021.09.007 · Cited by 12
SARS-CoV-2 Infection in Cancer Patients: A Population-Based Study
Zorzi, M., Guzzinati, S., Avossa, F., Fedeli, U., Calcinotto, A., & Rugge, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.730131 · Cited by 12
The needs of cancer patients during the COVID-19 pandemic—psychosocial, ethical and spiritual aspects—systematic review
Zapała, J., Matecka, M., Żok, A., & Baum, E. (2022) · PeerJ · doi:10.7717/peerj.13480 · Cited by 13
Impact of COVID-19 in Patients with Lung Cancer: A Descriptive Analysis
Mojsak, D., Dębczyński, M., Kuklińska, B., Minarowski, Ł., Kasiukiewicz, A., Moniuszko-Malinowska, A. M., Czupryna, P., & Mróz, R. M. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20021583 · Cited by 14
Lung tumor immunity: redirecting macrophages through infection-induced inflammation
Aktay-Cetin, Ö., Pullamsetti, S. S., Herold, S., & Savai, R. (2025) · Trends in Immunology · doi:10.1016/j.it.2025.04.004 · Cited by 14
Outpatient clinical pharmacy practice in the face of COVID-19 at a cancer center in New York City
Yerram, P., Thackray, J., Modelevsky, L. R., Land, J. D., Reiss, S., Spatz, K., LeVoir, A., Pak, T., Dao, P. H., Buege, M. J., et al. (2021) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155220987625 · Cited by 12
Self-citation
COVID-19 in patients with cancer: Risks and precautions
Razavi, A., Hamblin, M. R., & Rezaei, N. (2021) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2021.01.067 · Cited by 12
Evaluating the longitudinal effectiveness of preventive measures against COVID-19 and seroprevalence of IgG antibodies to SARS-CoV-2 in cancer outpatients and healthcare workers
Fong, D., Nicolò, K. O. S., Alber, M., & Mitterer, M. (2021) · Wiener klinische Wochenschrift · doi:10.1007/s00508-020-01807-6 · Cited by 12
IMPACT OF COVID-19 IN PATIENTS WITH CANCER: A SCOPING REVIEW
da Silva, T. T. M., de Araújo, N. M., Sarmento, S. D. G., de Castro, G. L. T., Dantas, D. V., & Dantas, R. A. N. (2021) · Texto & Contexto - Enfermagem · doi:10.1590/1980-265x-tce-2020-0415 · Cited by 12
Effect of COVID-19 Pandemic on Gynecological Cancer Radiation During Complete Nationwide Lockdown: Observations and Reflections From Tertiary Care Institute in India
Shinghal, A., Paul, S., Chopra, S., Gurram, L., Scaria, L., Kohle, S., Rane, P. H., Dheera, A., Puravath, J., Jain, J., et al. (2021) · Advances in Radiation Oncology · doi:10.1016/j.adro.2021.100725 · Cited by 12
Characteristics and outcomes of COVID-19 infection in 45 patients with breast cancer: A multi-center retrospective study in Hubei, China
Wei, J., Wu, M., Liu, J., Wang, X., Xia, P., Peng, L., Huang, Y., Liu, C., Xia, Z., Chen, C., et al. (2021) · The Breast · doi:10.1016/j.breast.2021.06.006 · Cited by 12
Self-citation
Molecular modeling piloted analysis for semicarbazone derivative of curcumin as a potent Abl-kinase inhibitor targeting colon cancer
Rodrigues, F. C., Hari, G., Pai, K. S. R., Suresh, A., Nayak, U. Y., Kumar, N. V. A., & Thakur, G. (2021) · 3 Biotech · doi:10.1007/s13205-021-03051-9 · Cited by 12
Gender differences in adherence to COVID-19 preventative measures and preferred sources of COVID-19 information among adolescents and young adults with cancer
Yan, A. P., Howden, K., Mahar, A. L., Glidden, C., Garland, S. N., & Oberoi, S. (2022) · Cancer Epidemiology · doi:10.1016/j.canep.2022.102098 · Cited by 12
Cancer and COVID-19 Susceptibility and Severity: A Two-Sample Mendelian Randomization and Bioinformatic Analysis
Zhang, Y., Mao, Q., Li, Y., Cheng, J., Xia, Q., Chen, G., Chen, P., Jin, S., Li, D., Zhong, C., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.759257 · Cited by 12
Self-citation
Immunouniverse of SARS-CoV-2
Jiménez, D., & Arias, M. T. (2022) · Immunological Medicine · doi:10.1080/25785826.2022.2066251 · Cited by 12
The impact of COVID-19 on cancer care in a tertiary hospital in Korea: possible collateral damage to emergency care
Yoo, S. H., Sim, J.-A., Shin, J., Keam, B., Park, J., & Shin, A. (2022) · Epidemiology and Health · doi:10.4178/epih.e2022044 · Cited by 12
Mortality in patients with cancer and SARS-CoV-2 infection: Results from the Argentinean Network of Hospital-Based Cancer Registries
Fattore, G. L., Olivos, N. S. A., Olalla, J. E. C., Gomez, L., Marucco, A. F., & Mena, M. P. R. (2022) · Cancer Epidemiology · doi:10.1016/j.canep.2022.102200 · Cited by 12
The Impact of COVID-19 Pandemic on Surgical Treatment of Resectable Non-Small Cell Lung Cancer in Greece
Tomos, I. P., Kapetanakis, E. I., Dimakopoulou, K., Raptakis, T., Kampoli, K., Karakatsani, A., Koumarianou, A. A., Papiris, S. A., & Tomos, P. I. (2023) · Life · doi:10.3390/life13010218 · Cited by 12
Severity and risk of COVID ‐19 in cancer patients: An evidence‐based learning
Sharma, A. M., Malviya, R., Kumar, V., Gupta, R., & Awasthi, R. (2020) · Dermatologic Therapy · doi:10.1111/dth.13778 · Cited by 12
Atypical Skin Manifestations During Immune Checkpoint Blockage in Coronavirus Disease 2019–Infected Patients With Lung Cancer
Rolfo, C. D., Cardona, A. F., Ruíz-Patiño, A., Ariza, S. A., Zatarain-Barrón, L., Pino, L. E., Viola, L., Russo, A., Rojas, L., Ricaurte, L., et al. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.06.019 · Cited by 12
Roadmap to resuming care for liver diseases after coronavirus disease‐2019
Kapuria, D., Bollipo, S. J., Rabiee, A., Yakov, G. B., Kumar, G., Siau, K., Lee, H. W., Congly, S. E., Turnés, J., Dhanasekaran, R., et al. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15178 · Cited by 12
The management of hematologic malignancies during the COVID-19 pandemic
Hus, I., Salomon‐Perzyński, A., Tomasiewicz, K., & Robak, T. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1849143 · Cited by 14
Is COVID-19–Induced Platelet Activation a Cause of Concern for Patients with Cancer?
Lichtenberger, L. M., & Vijayan, K. V. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-3691 · Cited by 12
SARS‐CoV‐2 nosocomial infection: Real‐world results of environmental surface testing from a large tertiary cancer center
Shah, M. R., Jan, I., Johns, J., Singh, K., Kumar, P. P., Belarmino, N., Saggiomo, K., Hayes, C., Washington, K., Toppmeyer, D., et al. (2021) · Cancer · doi:10.1002/cncr.33453 · Cited by 12
Evidence for residual SARS-CoV-2 in glioblastoma tissue of a convalescent patient
Lei, J., Liu, Y., Xie, T., Yao, G., Wang, G., Diao, B., & Song, J. (2021) · Neuroreport · doi:10.1097/wnr.0000000000001654 · Cited by 12
Self-citation
FURIN correlated with immune infiltration serves as a potential biomarker in SARS-CoV-2 infection-related lung adenocarcinoma
Luo, L., Li, M., Su, J., Yao, X., & Luo, H. (2021) · Clinical and Experimental Medicine · doi:10.1007/s10238-021-00760-6 · Cited by 12
Clinical outcomes in cancer patients with COVID ‐19
Sawyers, A., Chou, M. M., Johannet, P. M., Gulati, N., Qian, Y., Zhong, J., & Osman, I. (2021) · Cancer Reports · doi:10.1002/cnr2.1413 · Cited by 12
The Potential Mechanism of Cancer Patients Appearing More Vulnerable to SARS-CoV-2 and Poor Outcomes: A Pan-Cancer Bioinformatics Analysis
Huang, X., Liang, H., Zhang, H., Tian, L., Cong, P., Wu, T., Zhang, Q., Gao, X., Li, W., Chen, A., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.804387 · Cited by 12
Self-citation
SARS-CoV-2 pharmacologic therapies and their safety/effectiveness according to level of evidence
Baroutjian, A., Sanchez, C., Boneva, D., McKenney, M., & Elkbuli, A. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.08.091 · Cited by 11
Anosmia but Not Ageusia as a COVID-19-Related Symptom among Cancer Patients—First Results from the PAPESCO-19 Cohort Study
Zhou, K., Blanc-Lapierre, A., Seegers, V., Boisdron‐Celle, M., Bigot, F., Bourdon, M., Mahammedi, H., Lambert, A., Campone, M., Conroy, T., et al. (2021) · Cancers · doi:10.3390/cancers13143389 · Cited by 11
Use of proton pump inhibitors are associated with higher mortality in hospitalized patients with COVID-19
Wu, S., Jin, Z., Peng, C., Li, D., Cheng, Y., Zhu, R., He, J., & Wu, C. (2022) · Journal of Global Health · doi:10.7189/jogh.12.05005 · Cited by 11
Factors that predict severity of infection and seroconversion in immunocompromised children and adolescents with COVID-19 infection
Shanap, M. A., Sughayer, M. A., Alsmadi, O. A., Elzayat, I., Nuirat, A. A., Tbakhi, A., & Sultan, I. Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.919762 · Cited by 11
The impact of the COVID-19 pandemic on palliative care practice: A survey of clinical oncologists
Wang, Y., Huang, Y.-L., Ma, X., Wusiman, D., Zhang, X.-Q., & Bi, N. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1020937 · Cited by 10
A systematic review on impact of SARS-CoV-2 infection
Gowripriya, T., Radhakrishnan, Y., Ramamurthi, S., Bhaskar, J. P., & Balamurugan, K. (2023) · Microbiological Research · doi:10.1016/j.micres.2023.127364 · Cited by 12
Risk assessment and clinical implications of COVID-19 in multiple myeloma patients: A systematic review and meta-analysis
Mahmud, S. A. S., Hossain, M. F., Muyeed, A., Nazneen, S., Haque, M. A., Mazumder, H., & Mohsin, M. (2024) · PLoS ONE · doi:10.1371/journal.pone.0308463 · Cited by 11
Linking COVID-19 and cancer: Underlying mechanism
Tyagi, S., Tyagi, N., Singh, A., Gautam, A., Singh, A., Jindal, S., Singh, R. P., Chaturvedi, R., & Kushwaha, H. R. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167563 · Cited by 12
SARS-CoV-2 nucleocapsid protein interaction with YBX1 displays oncolytic properties through PKM mRNA destabilization
Chen, X., Jiang, B., Gu, Y., Yue, Z., Liu, Y., Lei, Z., Yang, G. H., Deng, M., Zhang, X., Luo, Z., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02153-1 · Cited by 11
Self-citation
COVID-19 Vaccine Booster Uptake and Effectiveness Among US Adults With Cancer
Skarbinski, J., Elkin, E. P., Ziemba, Y. C., Kazemian, E., Wilson, B. M., Siddiqui, H., Schleicher, C. B., Hsiao, C. A., Nugent, J. R., Reckamp, K. L., et al. (2025) · JAMA Oncology · doi:10.1001/jamaoncol.2025.2020 · Cited by 13
Resumption of elective surgery during the COVID-19 pandemic: what lessons can we apply?
Olson, M. T., Triantafyllou, T., & Singhal, S. (2020) · European surgery. Supplement/European surgery · doi:10.1007/s10353-020-00645-0 · Cited by 11
The Potential Role of Immune Alteration in the Cancer–COVID19 Equation—A Prospective Longitudinal Study
Goshen‐Lago, T., Szwarcwort‐Cohen, M., Benguigui, M., Almog, R., Turgeman, I., Zaltzman, N., Halberthal, M., Shaked, Y., & Ben‐Aharon, I. (2020) · Cancers · doi:10.3390/cancers12092421 · Cited by 11
The Use of Mobile-technologies to Deliver Integrative Medicine During and Beyond the COVID-19 World Pandemic
Narayanan, S., Lopez, G., Liu, W., Cohen, A., & Cohen, L. G. (2020) · Global Advances in Health and Medicine · doi:10.1177/2164956120977437 · Cited by 11
The Right Immune-Modulation at the Right Time: Thymosin α1 for Prevention of Severe COVID-19 in Cancer Patients
Bersanelli, M., Giannarelli, D., Leonetti, A., Buti, S., Tiseo, M., Nouvenne, A., Ticinesi, A., Meschi, T., Procopio, G., & Danielli, R. (2021) · Future Oncology · doi:10.2217/fon-2020-0754 · Cited by 11
Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer?
Ayhan, M., Laçin, Ş., Özyükseler, D. T., Sürmeli, H., Doğan, A., Turan, M., Odabaş, H., Turan, N., & Yıldırım, M. E. (2021) · Journal of Oncology Pharmacy Practice · doi:10.1177/10781552211015762 · Cited by 11
Impact of anti-cancer therapy on disease severity and mortality in cancer patients with COVID-19: a systematic review and meta-analysis
Lin, Z., Chen, J., & Han, S. (2021) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2021.1927721 · Cited by 12
Impact of COVID‐19 lockdown on routine oncology versus emergency care at a high volume cancer centre
Minichsdorfer, C., Jeryczynski, G., Krall, C., Achhorner, A. M., Caraan, A., Pasalic, S., Reininger, K., Wagner, C., Bartsch, R., Preusser, M., et al. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13623 · Cited by 11
COVID-19 vaccine development from the perspective of cancer patients
He, Y. M., Ding, Y., Cao, B., Huang, Y., & Wang, X. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1943988 · Cited by 10
Medical Oncology Group of Australia position statement: COVID ‐19 vaccination in patients with solid tumours
Kanjanapan, Y., Blinman, P. L., Underhill, C. R., Karikios, D. J., Segelov, E., & Yip, D. (2021) · Internal Medicine Journal · doi:10.1111/imj.15339 · Cited by 11
Clinical-Pathological Correlation of the Pathophysiology and Mechanism of Action of COVID-19 — a Primer for Clinicians
Chee, J., Loh, W. S., Liu, Z., Mullol, J., & Wang, D. Y. (2021) · Current Allergy and Asthma Reports · doi:10.1007/s11882-021-01015-w · Cited by 10
Does prior exposure to immune checkpoint inhibitors treatment affect incidence and mortality of COVID-19 among the cancer patients: The systematic review and meta-analysis
Liu, Y., Liu, S., Qin, Y., Zhao, L., Li, Y., Zhou, C., & Chen, W. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108242 · Cited by 11
Self-citation
Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies
Bozdağ, S. C., Seval, G. C., Hindilerden, İ. Y., Hindilerden, F., Andıç, N., Baydar, M., Kaynar, L. A., Toprak, S. K., Göksoy, H. S., Aydın, B. B., et al. (2021) · Turkish Journal of Hematology · doi:10.4274/tjh.galenos.2021.2021.0287 · Cited by 11
Decreased TMPRSS2 expression by SARS-CoV-2 predicts the poor prognosis of lung cancer patients through metabolic pathways and immune infiltration
Liu, X., Liu, B., Shang, Y., Cao, P., Hou, J., Chen, F., Zhang, B., Fan, Y., & Tan, K. (2022) · Aging · doi:10.18632/aging.203823 · Cited by 11
Consequences of the COVID-19 pandemic on lung cancer care and patient health in a German lung cancer center: results from a cross-sectional questionnaire
Walter, J., Sellmer, L., Kahnert, K., Kiefl, R., Syunyaeva, Z., Kauffmann-Guerrero, D. E., Manapov, F., Schneider, C. P., Behr, J., & Tufman, A. (2022) · Respiratory Research · doi:10.1186/s12931-022-01931-z · Cited by 11
Oncological Care During First Peruvian National Emergency COVID-19 Pandemic: A Multicentric Descriptive Study
Valdiviezo, N., Alcarraz, C., Castro, D., Salas, R., Begazo-Mollo, V., Galvez-Villanueva, M., Medina-Aguirre, L., Garcia-León, E., Quispe-Santivañez, I., Cornejo-Raymundo, C., et al. (2022) · Cancer Management and Research · doi:10.2147/cmar.s350038 · Cited by 11
Mortality in cancer patients with SARS-CoV-2 or seasonal influenza: an observational cohort study from a German-wide hospital network
Kodde, C., Bonsignore, M., Schöndube, D., Bauer, T. T., Hohenstein, S., Bollmann, A., Meier‐Hellmann, A., Kuhlen, R., & Nachtigall, I. (2022) · Infection · doi:10.1007/s15010-022-01852-5 · Cited by 11
Delineating the SARS-CoV-2 Induced Interplay between the Host Immune System and the DNA Damage Response Network
Papanikolaou, C., Rapti, V., Stellas, D., Stefanou, D. T., Syrigos, K., Pavlakis, G. N., & Souliotis, V. L. (2022) · Vaccines · doi:10.3390/vaccines10101764 · Cited by 12
Cerebrovascular accident in a child with precursor B-cell acute lymphoblastic leukemia and coronavirus disease 2019: a case report
Karimi, H., Sarmadian, R., Gilani, A., Salajegheh, P., Biglari, H. N., & Gholizadeh, M. (2022) · Journal of Medical Case Reports · doi:10.1186/s13256-022-03672-5 · Cited by 11
Comorbidities in the COVID-19 Pandemic: Scopus-Based Bibliometric Analysis
Fedorchenko, Y., & Zimba, O. (2023) · Journal of Korean Medical Science · doi:10.3346/jkms.2023.38.e93 · Cited by 11
COVID−19 hospitalization increases the risk of developing glioblastoma: a bidirectional Mendelian-randomization study
Dong, J., Wang, S., Xie, H., Mou, Y., Zhu, H., Peng, Y., Xi, J., Zhong, M., Xie, Z., Jiang, Z., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1185466 · Cited by 11
Self-citation
Initiation of the Global Coalition for Radiotherapy during the COVID-19 pandemic
Price, P., & Barney, S. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30281-3 · Cited by 11
Impact of the pandemic on cancer care: Lessons learnt from a rural cancer center in the first 3 months
Deshmukh, S. P., Naik, S., Zade, B., Patwa, R., Gawande, J. S., Watgaonkar, R., Wagh, S., Deshmukh, S., Gautam, P., Gandhi, V., et al. (2020) · Journal of Surgical Oncology · doi:10.1002/jso.26144 · Cited by 11
Expression and Clinical Significance of SARS-CoV-2 Human Targets in Neoplastic and Non-Neoplastic Lung Tissues
Subbarayan, K., Ulagappan, K., Wickenhauser, C., & Seliger, B. (2020) · Current Cancer Drug Targets · doi:10.2174/1568009620666201207145019 · Cited by 11
Safety of current immune checkpoint inhibitors in non-small cell lung cancer
Abdayem, P., & Planchard, D. (2021) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2021.1867100 · Cited by 10
Implications of mRNA-based SARS-CoV-2 vaccination for cancer patients
Romano, E., Pascolo, S., & Ott, P. A. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002932 · Cited by 11
Development and validation of a clinical prediction model to estimate the risk of critical patients with COVID‐19
Chen, W., Yao, M., Hu, L. T., Zhang, Y., Zhou, Q., Ren, H., Sun, Y., Zhang, M., & Xu, Y. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27428 · Cited by 10
Self-citation
Seroconversion rate after COVID-19 vaccination in patients with solid cancer: A systematic review and meta-analysis
Yin, J., Chen, Y., Li, Y., Zhang, X., & Wang, C. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2119763 · Cited by 11
Self-citation
Impact de la pandémie de COVID-19 sur les prises en charge pour cancer du sein et gynécologique
Gosset, M., Gal, J., Schiappa, R., Dejode, M., Fouché, Y., Alazet, F., Roux, E. L., Delpech, Y., & Barranger, E. (2020) · Bulletin du Cancer · doi:10.1016/j.bulcan.2020.10.013 · Cited by 10
What is the Safety of COVID-19 Vaccines in Immunocompromised Patients? Results from the European “Covid Vaccine Monitor” Active Surveillance Study
Bellitto, C., Luxi, N., Ciccimarra, F., L’Abbate, L., Raethke, M., van Hunsel, F. P. A. M., Lieber, T., Mulder, E., Riefolo, F., Villalobos, F., et al. (2024) · Drug Safety · doi:10.1007/s40264-024-01449-x · Cited by 10
A COVID-19 screening tool for oncology telephone triage
Elkin, E., Viele, C. S., Schumacher, K. L., Boberg, M., Cunningham, M., Liu, L., & Miaskowski, C. A. (2020) · Supportive Care in Cancer · doi:10.1007/s00520-020-05713-5 · Cited by 10
Analysis of Worldwide Surgical Outcomes in COVID-19-Infected Patients: a Gynecological Oncology Perspective
Phelps, D. L., Saso, S., & Ghaem‐Maghami, S. (2020) · Future Science OA · doi:10.2144/fsoa-2020-0099 · Cited by 10
Perioperative SARS-CoV-2 infection among women undergoing major gynecologic cancer surgery in the COVID-19 era: A nationwide, cohort study from Turkey
Ayhan, A., Öz, M., Özkan, N. T., Aslan, K., ALTINTAŞ, M. İ., Akıllı, H., Demirtaş, E., Çelik, O., Ülgü, M. M., Birinci, Ş., et al. (2020) · Gynecologic Oncology · doi:10.1016/j.ygyno.2020.11.014 · Cited by 10
Coronavirus Disease 2019 Infection in a Patient Population with Lung Cancer: Incidence, Presentation, and Alternative Diagnostic Considerations
Piper‐Vallillo, A. J., Mooradian, M. J., Meador, C. B., Yeap, B. Y., Peterson, J., Sakhi, M., Do, A., Zubiri, L., Stevens, S. E., Vaughn, J., et al. (2020) · JTO Clinical and Research Reports · doi:10.1016/j.jtocrr.2020.100124 · Cited by 10
SARS-CoV-2 infection in patients with primary central nervous system lymphoma
Laurenge, A., Ursu, R., Houillier, C., Abdi, B., Tebano, G., Quémeneur, C., Choquet, S., Blasi, R. D., Lozano-Sánchez, F. A., Morales-Martínez, A., et al. (2021) · Journal of Neurology · doi:10.1007/s00415-020-10311-w · Cited by 10
Analysis of the Effect of Proton-Pump Inhibitors on the Course of COVID-19
Zhang, X., Li, T., Wu, H., Ling, Y., Qian, Z., & Chen, L. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s292303 · Cited by 10
The Unique Balancing Act of Managing Children With Cancer and COVID-19 Infection: A Single Center Experience From South India
Totadri, S., Srinivasan, H. N., Joseph, L. L., Boddu, D., Kochath, P. S., Moorthy, M., Mathew, L. G., & John, R. R. (2021) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000002148 · Cited by 10
Estrogen and Estrogen Receptor Modulators: Potential Therapeutic Strategies for COVID-19 and Breast Cancer
Hu, S., Yin, F., Nie, L., Wang, Y., Qin, J., & Chen, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.829879 · Cited by 10
Prospective Medicinal Plants and Their Phytochemicals Shielding Autoimmune and Cancer Patients Against the SARS-CoV-2 Pandemic: A Special Focus on Matcha
Kiriacos, C. J., Khedr, M. R., Tadros, M., & Youness, R. A. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.837408 · Cited by 11
Impact of COVID-19 pandemic on clinicopathological features of transplant recipients with hepatocellular carcinoma: A case-control study
Akbulut, S., Şahin, T. T., İnce, V., & Yılmaz, S. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i15.4785 · Cited by 10
Global reported impacts of COVID ‐19 on lymphoma patients and the emerging clinical management approaches in response to the ongoing pandemic
Elliott, E. K., Hensen, R., Haupt, L. M., & Griffiths, L. R. (2023) · European Journal Of Haematology · doi:10.1111/ejh.13926 · Cited by 10
Percepción de la Pandemia COVID-19 en los Servicios de Cirugía en Colombia
Diaz-Castrillon, C. E., Cortés, N., Rey, S., Pineda, M., Díaz-Castrillón, J. F., & Tobón, S. S. (2020) · Revista Colombiana de Cirugía · doi:10.30944/20117582.655 · Cited by 17
Screening Strategies for COVID-19 in Patients With Hematologic Malignancies
Assi, T., Samra, B., Dercle, L., Rassy, E., Kattan, J. G., Ghosn, M. G., Houot, R., & Ammari, S. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01267 · Cited by 10
COVID-19 and Cardiovascular Health Among Patients with Cancer
Palaskas, N. L., Koutroumpakis, E., & Deswal, A. M. (2020) · Current Cardiology Reports · doi:10.1007/s11886-020-01421-y · Cited by 10
The Impact of COVID-19 Pandemic on Lung Cancer Community
Wu, L., Zhang, C., & Zhao, X. (2021) · World Journal of Oncology · doi:10.14740/wjon1367 · Cited by 10
Remote Home Monitoring of Patients With Cancer During the COVID Pandemic: A Pilot Study
Steimer, M., Leabo, J., Wang, H., Heyer, D. M., Addison, N., Bowles, N., Cannon, T. L., Cuevo, R. S., Ershler, W. B., Shafer, D. A., et al. (2021) · JCO Oncology Practice · doi:10.1200/op.20.00995 · Cited by 10
Self-citation
Rapid real‐world data analysis of patients with cancer, with and without COVID ‐19, across distinct health systems
Hwang, C., Izano, M. A., Thompson, M. A., Gadgeel, S. M., Weese, J. L., Mikkelsen, T., Schrag, A., Teka, M., Walters, S., Wolf, F. M., et al. (2021) · Cancer Reports · doi:10.1002/cnr2.1388 · Cited by 10
Characteristics and outcomes of cancer patients with covid-19 at a safety-net hospital
Özer, M., Goksu, S. Y., Mahdi, M., & Gandhi, N. (2021) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2021.100418 · Cited by 10
COVID‐19 vaccination in pediatric cancer patients: A high priority
Charla, Y., Kalra, M., Chopra, N., & Choudhury, S. (2021) · Pediatric Blood & Cancer · doi:10.1002/pbc.29397 · Cited by 8
Hyperthermia ablation combined with transarterial chemoembolization versus monotherapy for hepatocellular carcinoma: A systematic review and meta‐analysis
Li, Z., Li, Q., Wang, X., Chen, W., Jin, X., Liu, X., Ye, F., Dai, Z., Zheng, X., Li, P., et al. (2021) · Cancer Medicine · doi:10.1002/cam4.4350 · Cited by 10
Self-citation
A review on protective roles and potential mechanisms of metformin in diabetic patients diagnosed with COVID-19
Kifle, Z. D., Woldeyohanins, A. E., & Demeke, C. A. (2021) · Metabolism Open · doi:10.1016/j.metop.2021.100137 · Cited by 10

Authors: Dai, M., Liu, D., Liu, M., Zhou, F., Li, G., Chen, Z., Zhang, Z., You, H., Wu, M., Zheng, Q., Xiong, Y., Xiong, H., Wang, C., Chen, C., Xiong, F., Zhang, Y., Peng, Y., Ge, S., Zhen, B., Yu, T., Wang, L., Wang, H., Liu, Y., Chen, Y., Mei, J., Gao, X., Li, Z., Gan, L., He, C., Li, Z., Shi, Y., Qi, Y., Yang, J., Tenen, D. G., Chai, L., Mucci, L. A., Santillana, M., & Cai, H.
Affiliations: Zhongnan Hospital of Wuhan University (CN)
Boston Children's Hospital (US)
Brigham and Women's Hospital (US)
Wuhan Union Hospital (CN)
Central Hospital of Wuhan (CN)
Huanggang Central Hospital (CN)
Guangzhou Medical University (CN)
Tongji Hospital (CN)
16Department of Radiology, Hubei Cancer Hospital, Wuhan, Hubei, China.
Hubei Cancer Hospital (CN)
Renmin Hospital of Wuhan University (CN)
19Department of Oncology, Wuhan Puren Hospital, Wuhan, Hubei, China.
Xianning Central Hospital (CN)
The Central Hospital of Xiao gan (CN)
22Department of Obstetrics and Gynecology, The People's Hospital of Huangmei, Huangmei, Hubei, China.
Hubei University of Medicine (CN)
Harvard University (US)
Corresponding author: Liu, Miao
Santillana, Mauricio
Cai, Hongbing
ORCID: Liu, Dianbo
Liu, Miao
Zhou, Fuxiang
Li, Guiling
Chen, Zhen
You, Hua
Wu, Meng
Xiong, Yong
Xiong, Huihua
Wang, Chun
Xiong, Fei
Zhang, Yan
Yu, Tingting
Wang, Ling
Wang, Hua
Liu, Yu
Li, Zhuyan
He, Can
Shi, Yuying
Qi, Yuwen
Yang, Jing
Tenen, Daniel G.
Chai, Li
Mucci, Lorelei A.
Santillana, Mauricio
Cai, Hongbing
Venue: Cancer Discovery
Publisher: American Association for Cancer Research (AACR)
Published: 2020-06-01
Volume: 10
Issue: 6
Pages: 783-791
ISSN: 2159-8274 (ISSN-L)
2159-8290
DOI: 10.1158/2159-8290.cd-20-0422
PMC: PMC7309152
OpenAlex: W3015599879
Cited by: 1,589
References: 27
Citations by year: 2026: 16 · 2025: 55 · 2024: 90 · 2023: 218 · 2022: 354 · 2021: 494 · 2020: 356
FWCI: 128.41
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Cancer Discovery (publishedVersion)
SSRN Electronic Journal (acceptedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Natural Science Foundation of China (8197103302/H16)
Singapore Ministry of Health's National Medical Research Council (MOH-STaR18nov-0002)
NIH NHLBI (P01HL095489)
Xiu Research Fund
Institutional Ethics Board of Zhongnan Hospital of Wuhan University (2020029)
Topics: Health Sciences › Medicine › Oncology › COVID-19 and healthcare impacts
Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Health Sciences › Medicine › Obstetrics and Gynecology › COVID-19 Impact on Reproduction
Keywords: COVID-19 pandemic, SARS-CoV-2, cancer patients, disease severity, hematologic malignancies, lung cancer, metastatic cancer, radiotherapy, infection susceptibility
MeSH terms: Betacoronavirus, COVID-19, SARS-CoV-2, Aged, China, Disease Outbreaks, Female, Humans, Intensive Care Units, Male, Middle Aged, Neoplasms, Pneumonia, Viral, Respiration, Artificial, Cohort Studies, Coronavirus Infections, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks